Abstract：
OBJECTIVE:To describe the legal, professional, and consumer status of prescribers dispensing legend and over-the-counter drugs in the United States. METHODS:Legal and academic databases were searched to identify those states that permit prescribers to dispense medications to patients and any limitations on such practice. In addition, prescribers and patients-consumers were surveyed to learn about the prevalence and perceptions of such practice. The use of drug samples was explicitly excluded from the study. MAIN RESULTS:Surveys were obtained from 556 physicians, 64 NPs, and 999 patient-consumers of drugs dispensed by prescribers. Forty-four states authorize prescriber dispensing. Midlevel practitioners (i.e., NPs and physician assistants) are authorized to dispense in 43 states. Thirty-two states do not require dispensing prescribers to compete additional registration to dispense medications, and 30 states require some level of compliance with pharmacy practice requirements. Prescriber dispensing is common, independent of patient age or insurance coverage. Prescriber dispensing appears driven by physician and patient perceptions of convenience and cost reductions. Future dispensing is likely to increase due to consumers' satisfaction with the practice. Consumer self-reported adverse drug reactions (ADRs) were equivalent between pharmacist- and physician-dispensed drugs, but urgent and emergency clinic ADR consultations were slightly lower with physician dispensing. CONCLUSIONS:Prescriber dispensing is firmly entrenched in the U.S. health care system, is likely to increase, does not appear to increase ADRs, and may reduce urgent care and emergency department visits. The reduction in urgent care and emergency department visits requires further study to confirm these preliminary findings.
journal_name
Pharmacotherapyjournal_title
Pharmacotherapyauthors
Munger MA,Ruble JH,Nelson SD,Ranker L,Petty RC,Silverstein S,Barton E,Feehan Mdoi
10.1002/phar.1461subject
Has Abstractpub_date
2014-10-01 00:00:00pages
1012-21issue
10eissn
0277-0008issn
1875-9114journal_volume
34pub_type
杂志文章相关文献
PHARMACOTHERAPY文献大全abstract：STUDY OBJECTIVE:To compare clinical and safety outcomes of warfarin therapy before and after implementation of a novel patient self-management (PSM) program in which patients received their venipuncture-derived international normalized ratio (INR) results through a secure online messaging system and adjusted their warf...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1002/phar.1139
更新日期：2012-12-01 00:00:00
abstract：:A 37-year-old Hispanic man with advanced acquired immunodeficiency syndrome developed extensive pulmonary disease with persistent cough, fever, night sweats, worsening dyspnea, and weight loss. Sputum samples showed scant growth of acid-fast bacilli. He failed to respond to the standard tuberculosis regimen of isoniaz...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1592/phco.26.11.1646
更新日期：2006-11-01 00:00:00
abstract：:A 53-year-old woman with an intraabdominal infection secondary to Candida albicans experienced hyperbilirubinemia after receiving amphotericin B in two different formulations--amphotericin B deoxycholate and amphotericin B lipid complex. Only a few case reports of amphotericin B-induced hyperbilirubinemia have been do...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1592/phco.26.7.1011
更新日期：2006-07-01 00:00:00
abstract：STUDY OBJECTIVE:To determine the number of women who have menopausal symptoms after discontinuing hormone therapy, to determine how many of these women subsequently require nonhormonal alternatives to manage their symptoms, and to assess the effectiveness of those therapies. DESIGN:One-year retrospective study. SETTI...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1592/phco.26.10.1403
更新日期：2006-10-01 00:00:00
abstract：:Pharmacists are uniquely qualified to play essential roles in the clinical implementation of pharmacogenomics. However, specific responsibilities and resources needed for these roles have not been defined. We describe roles for pharmacists that emerged in the clinical implementation of genotype-guided clopidogrel ther...
journal_title：Pharmacotherapy
pub_type： 杂志文章,评审
doi：10.1002/phar.1481
更新日期：2014-10-01 00:00:00
abstract：STUDY OBJECTIVE:To evaluate the level of agreement between two sets of criteria, the Thrombolysis in Myocardial Infarction (TIMI) criteria and investigator-developed criteria, for identifying bleeding events in patients who had undergone a percutaneous coronary intervention (PCI) and to measure length of hospital stay ...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1592/phco.27.1.36
更新日期：2007-01-01 00:00:00
abstract：STUDY OBJECTIVE:To evaluate the safety, tolerability, and pharmacokinetic profile of fosphenytoin, a water-soluble phenytoin prodrug, after intramuscular and intravenous administration. DESIGN:Open-label study of intramuscular administration, and double-blind, randomized study of intravenous administration. SETTING:S...
journal_title：Pharmacotherapy
pub_type： 临床试验,杂志文章,多中心研究,随机对照试验
doi：
更新日期：1996-07-01 00:00:00
abstract：:Aspirin has been used for the prevention and treatment of cardiovascular disease (CVD) for several decades. The efficacy of aspirin for secondary prevention of cardiovascular disease is well established, but the clinical benefit of aspirin for primary prevention of CVD is less clear. The primary literature suggests th...
journal_title：Pharmacotherapy
pub_type： 杂志文章,评审
doi：10.1002/phar.1127
更新日期：2012-11-01 00:00:00
abstract：:We present a case of eosinophilic pneumonia due to ceftaroline used for the treatment of methicillin-resistant Staphylococcus aureus bacteremia associated with a postoperative spinal infection. Our patient developed shortness of breath and hypoxemia on the fifth week of ceftaroline therapy. Chest imaging disclosed dif...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1002/phar.1286
更新日期：2013-07-01 00:00:00
abstract：:Little information has been published concerning differences among the benzodiazepines in treating hospitalized patients with severe symptoms of alcohol withdrawal. We attempted to determine the length and type of hospital stay, and the pattern and appropriateness of administration, dosage requirements, and costs asso...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：
更新日期：1994-09-01 00:00:00
abstract：:Low-molecular-weight heparins (LMWHs) are safe and effective in the treatment of venous thromboembolic disease. Since they require less therapeutic monitoring than unfractionated heparin and may be administered to outpatients, it is possible to decrease overall health care costs of patients diagnosed with deep vein th...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：
更新日期：1998-11-01 00:00:00
abstract：:Infections caused by yeasts and molds continue to be associated with high rates of morbidity and mortality in both immunocompromised and immunocompetent patients. Many antifungal drugs have been developed over the past 15 years to aid in the management of these infections. However, treatment is still not optimal, as t...
journal_title：Pharmacotherapy
pub_type： 杂志文章,评审
doi：10.1592/phco.28.5.614
更新日期：2008-05-01 00:00:00
abstract：:Ischemic stroke is a prevalent disease with a large burden on the health system. Preventive strategies, therefore, are paramount. Primary prevention is aimed at reducing the risk of stroke in asymptomatic people. The most effective prevention is through control of modifiable risk factors. Due to the large amount of li...
journal_title：Pharmacotherapy
pub_type：
doi：10.1002/phar.1255
更新日期：2013-06-01 00:00:00
abstract：:Status epilepticus (SE) has a high mortality rate and is one of the most common neurologic emergencies. Fast progression of this neurologic emergency and lack of response to traditional antiepileptic drugs (AEDs) in most cases has challenged clinicians to use new agents. This article evaluates the efficacy and safety ...
journal_title：Pharmacotherapy
pub_type： 杂志文章,评审
doi：10.1002/phar.2229
更新日期：2019-03-01 00:00:00
abstract：:Our objective was to describe the implementation and clinical outcomes of an employer-sponsored, pharmacist-provided medication therapy management (MTM) program for health plan beneficiaries with diabetes mellitus and/or hypertension. We conducted a single-center retrospective medical record review. The setting was a ...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1002/phar.1650
更新日期：2015-11-01 00:00:00
abstract：:A 69-year-old woman was admitted for control of intractable rectal pain caused by a 4-cm malignant mass. She was treated successfully with EMLA (eutectic mixture of local anesthetics) cream applied every 8 hours and covered with a Xeroform dressing. Despite an increase in tumor size to 6 cm, her pain control was maint...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：
更新日期：1996-07-01 00:00:00
abstract：:The National Kidney Foundation developed and oversees the Kidney Disease Outcomes Quality Initiative, a process that develops clinical practice guidelines in nephrology. Recent guidelines address the evaluation, classification, and stratification of chronic kidney disease (CKD). These guidelines provide, for the first...
journal_title：Pharmacotherapy
pub_type： 杂志文章,评审
doi：10.1592/phco.25.4.491.61034
更新日期：2005-04-01 00:00:00
abstract：:The National Academies of Sciences, Engineering, and Medicine has found substantial evidence that cannabis (plant) is effective for the treatment of chronic pain in adults, and moderate evidence that oromucosal cannabinoids (extracts, especially nabiximols) improve short-term sleep disturbances in chronic pain. The pa...
journal_title：Pharmacotherapy
pub_type： 杂志文章,评审
doi：10.1002/phar.2115
更新日期：2018-06-01 00:00:00
abstract：:In a double-blind, placebo-controlled study of 200 patients with moderate to moderately severe anxiety we compared the anxiolytic efficacy and safety of alprazolam and lorazepam. Dosing was flexible and ranged from 1 to 4.5 mg/day of alprazolam and from 2 to 9 mg/day of lorazepam. The mean daily dose at the end of the...
journal_title：Pharmacotherapy
pub_type： 临床试验,杂志文章
doi：10.1002/j.1875-9114.1984.tb03327.x
更新日期：1984-03-01 00:00:00
abstract：OBJECTIVE:To review the current pharmacotherapy for idiopathic pulmonary arterial hypertension (IPAH). METHODS:A search of the primary literature was conducted by using MEDLINE, the National Institutes of Health medical research Web site (www.clinicaltrials.gov), and the United States Food and Drug Administration's Ce...
journal_title：Pharmacotherapy
pub_type： 杂志文章,评审
doi：10.1592/phco.2006.26.1.68
更新日期：2006-01-01 00:00:00
abstract：:Warfarin is considered a high-risk drug because of its narrow therapeutic window, variability in dose response, and multitude of drug and food interactions. Although travel advice is available for patients who are taking warfarin, it is geared toward patients who are traveling to developed countries and tends to be la...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1002/j.1875-9114.2012.01019.x
更新日期：2012-03-01 00:00:00
abstract：STUDY OBJECTIVE:To determine the effects of mild-to-moderate induced hypothermia-a neuroprotectant and/or therapeutic strategy for the management of intracranial hypertension in neurologically injured patients-on the pharmacokinetics of aminoglycoside therapy. DESIGN:Pharmacokinetic analysis. SETTING:Critical care un...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1592/phco.30.7.654
更新日期：2010-07-01 00:00:00
abstract：:Highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) has resulted in significant morbidity and mortality reductions. Lifelong antiretroviral therapy must be incorporated into each patient's medical regimen. Patients with HIV may also have simultaneous chronic medical conditions, resultin...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1592/phco.28.7.945
更新日期：2008-07-01 00:00:00
abstract：:Death is the ultimate adverse drug event. Despite its importance, the frequency of fatal adverse drug events is unknown. Estimates in the United States are as high as 140,000/year, although this number is heavily disputed. Potential reasons and risks for fatal adverse drug events, as well as epidemiologic designs for ...
journal_title：Pharmacotherapy
pub_type： 杂志文章,评审
doi：10.1592/phco.21.6.521.34540
更新日期：2001-05-01 00:00:00
abstract：:This study compared limited sampling methods (LSM) of estimating area under the plasma concentration versus time curve (AUC) based on a Bayesian regularized neural network, the Bayesian approach, and multiple forward stepwise regression models from selected concentration-time points. Plasma concentration versus time d...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1592/phco.23.8.1044.32872
更新日期：2003-08-01 00:00:00
abstract：OBJECTIVES:To examine the knowledge, attitudes, and interest of an inner-city population toward pharmacogenetic testing, with the primary objective of identifying facilitators and barriers toward pharmacogenetic testing; and secondary objectives of determining predictors of patient interest in pharmacogenetic testing a...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1002/phar.2077
更新日期：2018-02-01 00:00:00
abstract：STUDY OBJECTIVES:To examine potential threats to internal and external study validity caused by differential patient withdrawal from a randomized controlled trial evaluating pharmacist management of hypertension, to compare the characteristics of patients who withdrew with those of patients who completed the study, and...
journal_title：Pharmacotherapy
pub_type： 杂志文章,随机对照试验
doi：10.1592/phco.26.11.1565
更新日期：2006-11-01 00:00:00
abstract：:A 23-year-old man was brought to the emergency department after eating four boxes of brodifacoum-containing rodenticide over a 4-day interval and pieces from approximately two bottles of glass over the previous 2 weeks. He was asymptomatic but his prothrombin time was markedly elevated with an international normalized...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1592/phco.23.10.1186.32755
更新日期：2003-09-01 00:00:00
abstract：STUDY OBJECTIVE:To evaluate the accuracy of four equations based on serum creatinine concentration-the original Schwartz equation and the Leger, Bedside Chronic Kidney Disease in Children (CKiD), and Counahan-Barratt equations-for determining glomerular filtration rate (GFR) in pediatric patients with chronic kidney di...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1002/j.1875-9114.2012.01095.x
更新日期：2012-07-01 00:00:00
abstract：:Methotrexate, administered for treatment of pediatric and adult malignancies, is a direct renal toxin, which can lead to renal dysfunction, decreased methotrexate clearance, elevated methotrexate concentrations, and systemic toxicity. Although plasma methotrexate concentrations have been shown to decline precipitously...
journal_title：Pharmacotherapy
pub_type： 杂志文章
doi：10.1592/phco.30.1.111
更新日期：2010-01-01 00:00:00
